{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T06:16:05Z","timestamp":1781849765374,"version":"3.54.5"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1097\/rlu.0b013e31815c4fd4","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T04:21:28Z","timestamp":1236226888000},"page":"8-13","source":"Crossref","is-referenced-by-count":38,"title":["F-18 FDG PET and PET\/CT Evaluation of Response to Chemotherapy in Bone and Soft Tissue Sarcomas"],"prefix":"10.1097","volume":"33","author":[{"given":"Andrei","family":"Iagaru","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rinat","family":"Masamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sant P.","family":"Chawla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence R.","family":"Menendez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Fedenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter S.","family":"Conti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210204","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3322\/canjclin.56.2.106","article-title":"Cancer statistics, 2006.","volume":"56","author":"Jemal","year":"2006","journal-title":"CA Cancer J Clin"},{"key":"R2-3-20210204","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0959-8049(99)00229-4","article-title":"Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group.","volume":"35","author":"Young","year":"1999","journal-title":"Eur J Cancer"},{"key":"R3-3-20210204","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ctrv.2003.07.004","article-title":"The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysis.","volume":"30","author":"Bastiaannet","year":"2004","journal-title":"Cancer Treat Rev"},{"key":"R4-3-20210204","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1097\/00003072-200011000-00004","article-title":"Evaluation of chemotherapy response in primary bone tumors with F-18 FDG positron emission tomography compared with histologically assessed tumor necrosis.","volume":"25","author":"Franzius","year":"2000","journal-title":"Clin Nucl Med"},{"key":"R5-3-20210204","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/cncr.20769","article-title":"Use of positron emission tomography in localized extremity soft tissue sarcoma treated with neoadjuvant chemotherapy.","volume":"103","author":"Schuetze","year":"2005","journal-title":"Cancer"},{"key":"R6-3-20210204","first-page":"1637","article-title":"Evaluation of neoadjuvant therapy response of osteogenic sarcoma using FDG PET.","volume":"40","author":"Schulte","year":"1999","journal-title":"J Nucl Med"},{"key":"R7-3-20210204","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00247-004-1192-x","article-title":"Imaging of malignant tumours of the long bones in children: monitoring response to neoadjuvant chemotherapy and preoperative assessment.","volume":"34","author":"Brisse","year":"2004","journal-title":"Pediatr Radiol"},{"key":"R8-3-20210204","first-page":"118","article-title":"Use of positron emission tomography in the evaluation of cryosurgical treatment of musculoskeletal tumors.","volume":"213","author":"Conti","year":"1999","journal-title":"Radiology"},{"key":"R9-3-20210204","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1200\/JCO.2000.18.1.4","article-title":"Prognostic factors in nonmetastatic Ewing's sarcoma of bone treated with adjuvant chemotherapy: analysis of 359 patients at the Istituto Ortopedico Rizzoli.","volume":"18","author":"Bacci","year":"2000","journal-title":"J Clin Oncol"},{"key":"R10-3-20210204","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1200\/JCO.2001.19.13.3203","article-title":"Treatment-induced pathologic necrosis: a predictor of local recurrence and survival in patients receiving neoadjuvant therapy for high-grade extremity soft tissue sarcomas.","volume":"19","author":"Eilber","year":"2001","journal-title":"J Clin Oncol"},{"key":"R11-3-20210204","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00256-002-0607-8","article-title":"FDG PET imaging guided re-evaluation of histopathologic response in a patient with high-grade sarcoma.","volume":"32","author":"Vernon","year":"2003","journal-title":"Skeletal Radiol"},{"key":"R12-3-20210204","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0098-2997(93)90016-7","article-title":"Ifosfamide induced stress response in human lymphocytes.","volume":"14","author":"Issels","year":"1993","journal-title":"Mol Aspects Med"},{"key":"R14-3-20210204","first-page":"1438","article-title":"Monitoring of neoadjuvant therapy response of soft-tissue and musculoskeletal sarcoma using fluoring-18-FDG PET.","volume":"37","author":"Jones","year":"1996","journal-title":"J Nucl Med"},{"key":"R15-3-20210204","first-page":"984","article-title":"FDG-PET to evaluate response to hyperthermic isolated limb perfusion for locally advance soft-tissue sarcoma.","volume":"37","author":"van Ginkel","year":"1996","journal-title":"J Nucl Med"},{"key":"R16-3-20210204","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s004320050217","article-title":"Local host response in osteosarcoma after chemotherapy referred to radiographs, CT, tumour necrosis and patient survival.","volume":"124","author":"Lindner","year":"1998","journal-title":"J Cancer Res Clin Oncol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00003072-200801000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T07:10:27Z","timestamp":1618038627000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-200801000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0b013e31815c4fd4","relation":{},"ISSN":["0363-9762"],"issn-type":[{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}